ATE535528T1 - Nalmefendiesterprodrugs - Google Patents
NalmefendiesterprodrugsInfo
- Publication number
- ATE535528T1 ATE535528T1 AT09734161T AT09734161T ATE535528T1 AT E535528 T1 ATE535528 T1 AT E535528T1 AT 09734161 T AT09734161 T AT 09734161T AT 09734161 T AT09734161 T AT 09734161T AT E535528 T1 ATE535528 T1 AT E535528T1
- Authority
- AT
- Austria
- Prior art keywords
- nalmefen
- prodrugs
- compounds
- diester prodrugs
- disorders
- Prior art date
Links
- 239000000651 prodrug Substances 0.000 title abstract 2
- 229940002612 prodrug Drugs 0.000 title abstract 2
- 150000005690 diesters Chemical class 0.000 title 1
- 208000007848 Alcoholism Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010012335 Dependence Diseases 0.000 abstract 1
- 208000026331 Disruptive, Impulse Control, and Conduct disease Diseases 0.000 abstract 1
- 208000001613 Gambling Diseases 0.000 abstract 1
- 208000030990 Impulse-control disease Diseases 0.000 abstract 1
- WJBLNOPPDWQMCH-MBPVOVBZSA-N Nalmefene Chemical compound N1([C@@H]2CC3=CC=C(C=4O[C@@H]5[C@](C3=4)([C@]2(CCC5=C)O)CC1)O)CC1CC1 WJBLNOPPDWQMCH-MBPVOVBZSA-N 0.000 abstract 1
- 206010034158 Pathological gambling Diseases 0.000 abstract 1
- 206010001584 alcohol abuse Diseases 0.000 abstract 1
- 201000007930 alcohol dependence Diseases 0.000 abstract 1
- 208000025746 alcohol use disease Diseases 0.000 abstract 1
- 238000001311 chemical methods and process Methods 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229960005297 nalmefene Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 201000009032 substance abuse Diseases 0.000 abstract 1
- 231100000736 substance abuse Toxicity 0.000 abstract 1
- 208000011117 substance-related disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Addiction (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08155092 | 2008-04-24 | ||
| PCT/EP2009/054875 WO2009130270A1 (en) | 2008-04-24 | 2009-04-23 | Nalmefene di-ester prodrugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE535528T1 true ATE535528T1 (de) | 2011-12-15 |
Family
ID=39760853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT09734161T ATE535528T1 (de) | 2008-04-24 | 2009-04-23 | Nalmefendiesterprodrugs |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20110053971A1 (de) |
| EP (1) | EP2307420B1 (de) |
| JP (1) | JP5426660B2 (de) |
| KR (1) | KR101598138B1 (de) |
| CN (1) | CN102036993B (de) |
| AT (1) | ATE535528T1 (de) |
| AU (1) | AU2009239927B2 (de) |
| CA (1) | CA2722243C (de) |
| CY (1) | CY1113040T1 (de) |
| DK (1) | DK2307420T3 (de) |
| ES (1) | ES2377599T3 (de) |
| HR (1) | HRP20120126T1 (de) |
| ME (1) | ME01295B (de) |
| PL (1) | PL2307420T3 (de) |
| PT (1) | PT2307420E (de) |
| RS (1) | RS52171B (de) |
| RU (1) | RU2495041C2 (de) |
| SI (1) | SI2307420T1 (de) |
| WO (1) | WO2009130270A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2291380T3 (da) * | 2008-04-24 | 2011-12-05 | Janssen Pharmaceutica Nv | Nalmefen-prodrugs |
| AR096851A1 (es) * | 2013-07-11 | 2016-02-03 | H Lundbeck As | Sales que no forman hidratos ni solvatos de nalmefeno |
| US10226456B2 (en) | 2015-04-27 | 2019-03-12 | 3St Research Llc | Methods and compositions for preventing opioid abuse |
| US10449190B2 (en) | 2015-04-27 | 2019-10-22 | John K. Thottathil | Alpha-hydroxy carboxylic acid and derivatives and other GRAS-based prodrugs of opioids and uses thereof |
| US10017519B2 (en) | 2015-04-27 | 2018-07-10 | 3St Research Llc | Alpha-hydroxy carboxylic acid and derivatives and other GRAS based prodrugs of oxycodone and uses thereof |
| EP3600319A4 (de) * | 2017-03-29 | 2020-11-25 | John K. Thottathil | Neuartige alpha-hydroxy-carbonsäure und derivate und andere gras-basierte prodrugs von opioiden und verwendungen davon |
| EP3703694A4 (de) | 2017-11-03 | 2021-08-18 | Nirsum Laboratories, Inc. | Opioidrezeptorantagonist-prodrugs |
| TW202015684A (zh) * | 2018-06-21 | 2020-05-01 | 景凱生物科技股份有限公司 | 那曲酮、納美芬及其衍生物之前藥 |
| WO2020226628A1 (en) * | 2019-05-07 | 2020-11-12 | Nirsum Laboratories, Inc. | Opioid receptor antagonist prodrugs for treating opioid dependence |
| CA3139168A1 (en) | 2019-05-07 | 2020-11-12 | Nirsum Laboratories, Inc. | Opioid receptor antagonist prodrugs |
| WO2023183795A1 (en) * | 2022-03-22 | 2023-09-28 | Elysium Therapeutics, Inc. | Opioid antagonist prodrugs and formulations for the reversal of opioid overdoses |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4673679A (en) * | 1986-05-14 | 1987-06-16 | E. I. Du Pont De Nemours And Company | Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration |
| US5086058A (en) * | 1990-06-04 | 1992-02-04 | Alko Ltd. | Method for treating alcoholism with nalmefene |
| JPH06271578A (ja) * | 1993-03-15 | 1994-09-27 | Natl Sci Council | 鎮痛剤ナルブフィン前薬の誘導体 |
| DE69427551T2 (de) * | 1993-03-15 | 2002-05-16 | National Science Council, Taipeh/T'ai-Pei | Nalbuphinester und diese enthaltende Arzneimittel mit verzögerter Wirkstoffabgabe |
| JP2005508888A (ja) * | 2001-08-14 | 2005-04-07 | バイオティ セラピーズ コーポレイション | アルコール依存症またはアルコール中毒を治療する方法 |
| GB0606124D0 (en) * | 2006-03-28 | 2006-05-03 | Reckitt Benckiser Healthcare | Buprenorphine derivatives and uses thereof |
-
2009
- 2009-04-23 EP EP09734161A patent/EP2307420B1/de active Active
- 2009-04-23 WO PCT/EP2009/054875 patent/WO2009130270A1/en active Application Filing
- 2009-04-23 DK DK09734161.4T patent/DK2307420T3/da active
- 2009-04-23 CN CN200980114294.8A patent/CN102036993B/zh active Active
- 2009-04-23 AT AT09734161T patent/ATE535528T1/de active
- 2009-04-23 ES ES09734161T patent/ES2377599T3/es active Active
- 2009-04-23 CA CA2722243A patent/CA2722243C/en active Active
- 2009-04-23 ME MEP-2012-11A patent/ME01295B/me unknown
- 2009-04-23 AU AU2009239927A patent/AU2009239927B2/en not_active Ceased
- 2009-04-23 US US12/937,577 patent/US20110053971A1/en not_active Abandoned
- 2009-04-23 RS RS20120050A patent/RS52171B/en unknown
- 2009-04-23 KR KR1020107025886A patent/KR101598138B1/ko active IP Right Grant
- 2009-04-23 PT PT09734161T patent/PT2307420E/pt unknown
- 2009-04-23 SI SI200930166T patent/SI2307420T1/sl unknown
- 2009-04-23 RU RU2010147832/04A patent/RU2495041C2/ru active
- 2009-04-23 JP JP2011505508A patent/JP5426660B2/ja active Active
- 2009-04-23 PL PL09734161T patent/PL2307420T3/pl unknown
-
2012
- 2012-02-06 HR HR20120126T patent/HRP20120126T1/hr unknown
- 2012-02-28 CY CY20121100204T patent/CY1113040T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2307420A1 (de) | 2011-04-13 |
| PL2307420T3 (pl) | 2012-04-30 |
| HRP20120126T1 (hr) | 2012-02-29 |
| DK2307420T3 (da) | 2012-02-27 |
| PT2307420E (pt) | 2012-02-14 |
| CN102036993B (zh) | 2014-06-25 |
| KR101598138B1 (ko) | 2016-02-29 |
| EP2307420B1 (de) | 2011-11-30 |
| KR20100134769A (ko) | 2010-12-23 |
| WO2009130270A1 (en) | 2009-10-29 |
| RS52171B (en) | 2012-08-31 |
| JP2011518804A (ja) | 2011-06-30 |
| AU2009239927B2 (en) | 2014-03-13 |
| JP5426660B2 (ja) | 2014-02-26 |
| ES2377599T3 (es) | 2012-03-29 |
| CY1113040T1 (el) | 2016-04-13 |
| CA2722243C (en) | 2016-05-31 |
| RU2495041C2 (ru) | 2013-10-10 |
| CA2722243A1 (en) | 2009-10-29 |
| RU2010147832A (ru) | 2012-05-27 |
| US20110053971A1 (en) | 2011-03-03 |
| SI2307420T1 (sl) | 2012-05-31 |
| AU2009239927A1 (en) | 2009-10-29 |
| CN102036993A (zh) | 2011-04-27 |
| ME01295B (me) | 2012-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE535528T1 (de) | Nalmefendiesterprodrugs | |
| CA2871471C (en) | Dna-pk inhibitors | |
| MX2013001970A (es) | Compuestos de pirrolopirimidina y usos de los mismos. | |
| PH12015501385A1 (en) | Autotaxin inhibitors | |
| MX2013009873A (es) | Inhibidores triciclicos de cinasas. | |
| MX353806B (es) | Quinolinas como moduladores de cinasas del receptor del factor de crecimiento de fibroblasto (fgfr). | |
| UA107783C2 (en) | Isoindoline compounds for use in treating cancer | |
| MA33803B1 (fr) | Inhibiteur de bromodomaine de benzodiazépine | |
| EA020330B3 (ru) | Хиназолиновые соединения | |
| WO2010147898A3 (en) | Small molecule inhibitors of spleen tyrosine kinase (syk) | |
| EA201200473A1 (ru) | Замещенные (гетероарилметил)тиогидантоины | |
| WO2011080568A8 (en) | Novel pyrimidine compounds as mtor and pi3k inhibitors | |
| MX349004B (es) | Nuevos compuestos. | |
| EA201200323A1 (ru) | Соединения и композиции, как ингибиторы протеинкиназы | |
| TN2014000016A1 (en) | 4 - piperidinyl compounds for use as tankyrase inhibitors | |
| PH12014501967B1 (en) | Benzodioxanes in combination with other actives for inhibiting leukotriene production | |
| MX2014013090A (es) | Derivados de pirrolotriazinona. | |
| MX2013012652A (es) | Derivados de n-[(1h-pirazol-1-il)aril]-1h-indol o 1h-indazol-3-carboxamida, su preparacion y su uso como antagonistas p2y12. | |
| SG195100A1 (en) | Hydroxymethylaryl-substituted pyrrolotriazines as alk1 inhibitors | |
| UA107183C2 (uk) | Феніламіно-ізонікотинамідні сполуки, їх застосування, фармацевтична композиція, що їх містить, та спосіб лікування гіперпроліферативних захворювань | |
| CY1112295T1 (el) | Προφαρμακα ναλμεφενης | |
| WO2011103028A3 (en) | Compositions and methods for inhibiting mmset | |
| WO2009151495A3 (en) | Oxazole compounds, compositions and methods of use | |
| UA106205C2 (ru) | Соединения боронатного эфира, фармацевтическая композиция (варианты), которая содержит их, и способ их получения (варианты) |